Resources > Pharmaceutical

Pharmaceutical Resources

White Paper

Proactive Regulatory Compliance for Biopharmaceutical Global Competitiveness

The writing is on the wall for the biotechnology and pharmaceutical industry: New markets matter. As blockbuster patents expire in the next five years, there are not enough new products in the pipeline to make up for those lost revenues. This could cripple the industry were it not for the emerging growth regions outside the developed U.S., European, and Japanese markets, where ...

Back   1  2